Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

AMS:CCEP - Euronext Amsterdam - GB00BDCPN049 - Common Stock - Currency: EUR

76.8  -1.6 (-2.04%)

Fundamental Rating

4

CCEP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 24 industry peers in the Beverages industry. CCEP has only an average score on both its financial health and profitability. CCEP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
CCEP had a positive operating cash flow in the past year.
Each year in the past 5 years CCEP has been profitable.
CCEP had a positive operating cash flow in each of the past 5 years.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

CCEP's Return On Assets of 4.56% is fine compared to the rest of the industry. CCEP outperforms 70.83% of its industry peers.
CCEP has a better Return On Equity (16.70%) than 83.33% of its industry peers.
CCEP has a Return On Invested Capital of 7.00%. This is comparable to the rest of the industry: CCEP outperforms 54.17% of its industry peers.
CCEP had an Average Return On Invested Capital over the past 3 years of 7.84%. This is in line with the industry average of 8.11%.
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROIC 7%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CCEP has a Profit Margin of 6.94%. This is comparable to the rest of the industry: CCEP outperforms 50.00% of its industry peers.
CCEP's Profit Margin has declined in the last couple of years.
CCEP has a Operating Margin of 10.46%. This is in the lower half of the industry: CCEP underperforms 70.83% of its industry peers.
In the last couple of years the Operating Margin of CCEP has declined.
Looking at the Gross Margin, with a value of 35.31%, CCEP is doing worse than 79.17% of the companies in the same industry.
In the last couple of years the Gross Margin of CCEP has remained more or less at the same level.
Industry RankSector Rank
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
Compared to 1 year ago, CCEP has more shares outstanding
CCEP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCEP has been reduced compared to a year ago.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.13. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.13, CCEP is doing good in the industry, outperforming 62.50% of the companies in the same industry.
CCEP has a debt to FCF ratio of 5.34. This is a neutral value as CCEP would need 5.34 years to pay back of all of its debts.
CCEP has a Debt to FCF ratio of 5.34. This is amongst the best in the industry. CCEP outperforms 87.50% of its industry peers.
CCEP has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
CCEP has a Debt to Equity ratio (1.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Altman-Z 2.13
ROIC/WACC0.94
WACC7.43%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP's Current ratio of 0.81 is on the low side compared to the rest of the industry. CCEP is outperformed by 75.00% of its industry peers.
CCEP has a Quick Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.62, CCEP is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.62
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The earnings per share for CCEP have decreased strongly by -15.31% in the last year.
The Earnings Per Share has been growing slightly by 5.80% on average over the past years.
The Revenue has grown by 11.67% in the past year. This is quite good.
CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%

3.2 Future

The Earnings Per Share is expected to grow by 9.46% on average over the next years. This is quite good.
CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.46% yearly.
EPS Next Y6.3%
EPS Next 2Y7.92%
EPS Next 3Y8.4%
EPS Next 5Y9.46%
Revenue Next Year4%
Revenue Next 2Y3.87%
Revenue Next 3Y3.92%
Revenue Next 5Y3.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

CCEP is valuated quite expensively with a Price/Earnings ratio of 25.02.
CCEP's Price/Earnings ratio is a bit more expensive when compared to the industry. CCEP is more expensive than 70.83% of the companies in the same industry.
CCEP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.79.
CCEP is valuated rather expensively with a Price/Forward Earnings ratio of 18.03.
62.50% of the companies in the same industry are cheaper than CCEP, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CCEP to the average of the S&P500 Index (21.38), we can say CCEP is valued inline with the index average.
Industry RankSector Rank
PE 25.02
Fwd PE 18.03
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

79.17% of the companies in the same industry are cheaper than CCEP, based on the Enterprise Value to EBITDA ratio.
CCEP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CCEP is cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.66
EV/EBITDA 14.59
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.97
PEG (5Y)4.31
EPS Next 2Y7.92%
EPS Next 3Y8.4%

3

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.42%.
CCEP's Dividend Yield is comparable with the industry average which is at 2.78.
CCEP's Dividend Yield is comparable with the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

The dividend of CCEP is nicely growing with an annual growth rate of 9.91%!
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

CCEP pays out 64.17% of its income as dividend. This is not a sustainable payout ratio.
CCEP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP64.17%
EPS Next 2Y7.92%
EPS Next 3Y8.4%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (4/25/2025, 7:00:00 PM)

76.8

-1.6 (-2.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)04-29 2025-04-29
Inst Owners35.56%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap35.35B
Analysts77.39
Price Target82.49 (7.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP64.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.99%
PT rev (3m)-1.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.51%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 25.02
Fwd PE 18.03
P/S 1.73
P/FCF 16.66
P/OCF 11.55
P/B 4.16
P/tB N/A
EV/EBITDA 14.59
EPS(TTM)3.07
EY4%
EPS(NY)4.26
Fwd EY5.55%
FCF(TTM)4.61
FCFY6%
OCF(TTM)6.65
OCFY8.66%
SpS44.4
BVpS18.44
TBVpS-19.44
PEG (NY)3.97
PEG (5Y)4.31
Profitability
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROCE 9.32%
ROIC 7%
ROICexc 7.57%
ROICexgc 42.27%
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
FCFM 10.38%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Debt/EBITDA 3.24
Cap/Depr 100.64%
Cap/Sales 4.59%
Interest Coverage 8.59
Cash Conversion 99.67%
Profit Quality 149.65%
Current Ratio 0.81
Quick Ratio 0.62
Altman-Z 2.13
F-Score5
WACC7.43%
ROIC/WACC0.94
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
EPS Next Y6.3%
EPS Next 2Y7.92%
EPS Next 3Y8.4%
EPS Next 5Y9.46%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%
Revenue Next Year4%
Revenue Next 2Y3.87%
Revenue Next 3Y3.92%
Revenue Next 5Y3.46%
EBIT growth 1Y-4.98%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year45.63%
EBIT Next 3Y18.13%
EBIT Next 5Y12.1%
FCF growth 1Y6.42%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y9.09%
OCF growth 3Y13.08%
OCF growth 5Y9.96%